Cross Country Healthcare Inc

Cross Country Healthcare Inc(CCRN)股票分析

$13.250

+0.011 (+0.08%)收盘时

Loading chart…
最高
13.260
开盘
13.250
成交量加权均价
13.25
成交量
2.33M
市值
472.93M
最低
13.240
成交额
30.85M
企业价值/息税折旧摊销前利润(TTM)
44.08

Cross Country Healthcare, Inc. is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, and healthcare leaders within nursing, allied, physician, and human resources; vendor neutral programs and managed service programs; education healthcare services; caregiver services to PACE programs, and outsourcing services. The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.

AI 分析 of Cross Country Healthcare Inc (CCRN)

持有

CCRN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who wants an immediate entry. The stock is essentially flat, technicals are mixed, there is no fresh news catalyst, analyst sentiment is not provided, and the proprietary trading signals show no buy setup today. I would not buy it now; I would hold off and wait for a clearer catalyst or stronger momentum.

分析师评级(8)

-27.09% 下跌空间
买入
6 买入
2 持有
0 卖出
当前: 13.25
最低
8.65
平均
9.66
最高
11.00

Wedbush

2026-03-19

目标价

$15

跑赢大盘

UBS

2026-03-06

目标价

$10

中性

Benchmark

2026-03-05

目标价

$14

买入

Wedbush

2026-02-03

目标价

$11

中性

Truist

2025-12-16

目标价

$10

持有

估值指标

Cross Country Healthcare Inc(CCRN)当前预期市盈率为 126.58,5 年平均预期市盈率为 36.93。

预期市盈率

严重高估
5 年均值 P/E
36.93
当前P/E
126.58
高估
77.24
低估
-3.38

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
10.43
当前EV/EBITDA
44.08
高估
19.78
低估
1.08

预期市销率

合理
5 年均值 P/S
0.41
当前P/S
0.42
高估
0.50
低估
0.33

Alphio AI 对 CCRN 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%CCRN

$11.28

情景价格

基

基准

基准 · 50%CCRN

$10.05

情景价格

悲

悲观

悲观 · 25%CCRN

$9.35

情景价格

持有 CCRN 的大户

M

Magnetar Capital Partners, LP

+ 持有CCRN

+2.74%

3个月收益率

事件时间线

2026-05-14 (ET)

07:40:00

Cross Country Healthcare Signs Exclusive 36-Month Partnership with Optime

2026-05-08 (ET)

08:30:00

Benchmark Downgrades Cross Country Healthcare to Hold

2026-05-07 (ET)

17:00:00

Company Reports Q1 Revenue of $241.06M, Exceeding Expectations

11:30:00

Citizens Analyst Downgrades Cross Country Healthcare to Market Perform

07:20:00

Wedbush Downgrades Cross Country Healthcare to Neutral, Price Target Cut to $13.25

资讯

CCRN 常见问题 —— 由 Alphio AI 解答

Cross Country Healthcare, Inc. is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, and healthcare leaders within nursing, allied, physician, and human resources; vendor neutral programs and managed service programs; education healthcare services; caregiver services to PACE programs, and outsourcing services. The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. It operates in the Industrials sector (SERVICES-HELP SUPPLY SERVICES industry).

CCRN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who wants an immediate entry. The stock is essentially flat, technicals are mixed, there is no fresh news catalyst, analyst sentiment is not provided, and the proprietary trading signals show no buy setup today. I would not buy it now; I would hold off and wait for a clearer catalyst or stronger momentum.

8 analysts cover CCRN: 6 rate it Buy, 2 Hold and 0 Sell. The average price target is 9.66.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易